Milestone Scientific INC 8-K filings

Milestone Scientific Inc. announced board director appointments and key shareholder approvals for share increases and equity plan amendments following its 2026 Annual Meeting.

Milestone Scientific Inc. announced that three of its directors have submitted notices to convert their outstanding promissory notes into common stock, contingent on the stock price reaching $0.50.

Milestone Scientific appoints two independent directors and transitions its Board Chair to Executive Chairman while restructuring founder Leonard Osser's compensation.

Milestone Scientific Inc. has announced the dismissal of CBIZ CPAs P.C. and the appointment of Grassi & Co., CPAs, P.C. as its new independent auditor.

Milestone Scientific Inc. has implemented a stock option exchange program for key executives and established a new performance-based restricted stock unit sub-plan.

Milestone Scientific Inc. has closed a $2.15 million private placement of units, consisting of common stock and warrants, to strengthen its balance sheet and fund commercial growth.

Milestone Scientific has amended its agreement with Innovest S.p.A. to facilitate an upcoming capital raise of at least $900,000.

Milestone Scientific Inc. filed an amendment to its 8-K to include an Amended and Restated Memorandum of Understanding with Innovest S.p.A. regarding a planned PIPE financing and a lock-up of approximately 8.9 million shares.

Milestone Scientific Inc. entered an Amended and Restated Memorandum of Understanding with Innovest S.p.A. for a 12-month lock-up on 11.31% of its shares held by BP4 S.r.l., contingent on a $2.5 million offering.

Milestone Scientific Inc. stockholders approved an increase in authorized common stock to 125 million shares and re-elected all six incumbent directors at their 2024 Annual Meeting.

Milestone Scientific Inc. announced the immediate resignation of Leonard A. Osser from its Board of Directors, effective November 7, 2025, though he will maintain involvement through employment and consulting agreements.

Milestone Scientific Inc. received a notice from NYSE American regarding non-compliance with continued listing standards, requiring a compliance plan by November 7, 2025.

Milestone Scientific Inc. announced the appointment of Eric C. Hines as its new President and Chief Executive Officer, effective July 31, 2025.

Milestone Scientific Inc. announced the appointment of Shanth Thiyagalingam as an independent director, effective May 14, 2025.

Milestone Scientific Inc. announces the resignation of Marcum LLP as its independent auditor and the engagement of CBIZ CPAs, effective April 22, 2025.

Milestone Scientific Inc. announces the immediate resignation of director Giandomenico Trombetta due to personal reasons.

Milestone Scientific has entered into a consulting agreement with its former CEO, Arjan Haverhals, effective January 1, 2025, to leverage his expertise in sales, business strategy, and international expansion.

Milestone Scientific's CEO, Arjan Haverhals, will retire at the end of 2024, with Chairman Neal Goldman stepping in as Interim CEO.

Milestone Scientific Inc. has published an investor presentation on its website, as disclosed in a recent 8-K filing.

Milestone Scientific Inc. successfully held its 2024 Annual Meeting, electing seven directors and ratifying Marcum LLP as its independent auditor.

Milestone Scientific received $1.98 million from Comcast Corporation through the sale of its unused tax benefits under the New Jersey Emerging Technology and Biotechnology Financial Assistance Program.

Milestone Scientific Inc. has completed a public offering of common stock, including the exercise of an over-allotment option, raising additional capital.